Actinium Pharmaceuticals, Inc. (ATNM)
1.08
+0.01
(+0.93%)
USD |
NYAM |
Oct 08, 16:00
1.08
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Price to Book Value : 1.121 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.110 |
| October 06, 2026 | 1.152 |
| October 05, 2026 | 1.245 |
| October 02, 2026 | 1.214 |
| October 01, 2026 | 1.193 |
| September 30, 2026 | 1.162 |
| September 29, 2026 | 1.183 |
| September 28, 2026 | 1.224 |
| September 25, 2026 | 1.245 |
| September 24, 2026 | 1.235 |
| September 23, 2026 | 1.224 |
| September 22, 2026 | 1.214 |
| September 21, 2026 | 1.245 |
| September 18, 2026 | 1.266 |
| September 17, 2026 | 1.235 |
| September 16, 2026 | 1.287 |
| September 15, 2026 | 1.297 |
| September 14, 2026 | 1.328 |
| September 11, 2026 | 1.453 |
| September 10, 2026 | 1.359 |
| September 09, 2026 | 1.276 |
| September 08, 2026 | 1.276 |
| September 04, 2026 | 1.069 |
| September 03, 2026 | 1.090 |
| September 02, 2026 | 1.038 |
| Date | Value |
|---|---|
| September 01, 2026 | 1.033 |
| August 31, 2026 | 1.058 |
| August 28, 2026 | 1.048 |
| August 27, 2026 | 1.038 |
| August 26, 2026 | 1.048 |
| August 25, 2026 | 1.121 |
| August 24, 2026 | 1.090 |
| August 21, 2026 | 1.141 |
| August 20, 2026 | 1.162 |
| August 19, 2026 | 1.172 |
| August 18, 2026 | 1.121 |
| August 17, 2026 | 1.090 |
| August 14, 2026 | 1.079 |
| August 13, 2026 | 1.000 |
| August 12, 2026 | 0.852 |
| August 11, 2026 | 0.8229 |
| August 10, 2026 | 0.7992 |
| August 07, 2026 | 0.8274 |
| August 06, 2026 | 0.8166 |
| August 05, 2026 | 0.7769 |
| August 04, 2026 | 0.8405 |
| August 03, 2026 | 0.842 |
| July 31, 2026 | 0.8684 |
| July 30, 2026 | 0.8685 |
| July 29, 2026 | 0.8684 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.578 |
| Alnylam Pharmaceuticals, Inc. | 22.17 |
| Savara, Inc. | 6.920 |
| Vericel Corp. | 5.538 |
| Biogen, Inc. | 1.712 |
Price to Book Value Related Metrics
| PE Ratio | 3.028 |
| PS Ratio | 0.9621 |
| Price | 1.08 |
| Earnings Yield | 33.03% |
| Market Cap | 33.96M |
| Operating PE Ratio | 3.533 |
| Normalized PE Ratio | 3.028 |